Public Calendar: January 5-11, 2020
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs
No Significant Event
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
Event Date: 01/07/2020
Location: Las Vegas, NV
Subject: Consumer Technology Association Conference (Consumer Electronics Show (CES)): Digital Health Summit; Speaker: Demystifying Regulations
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
No Significant Event
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name: Laura Caliguiri, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
Event Date: 01/11/2020
Location: San Francisco, CA
Subject: University of California San Francisco (UCSF) Roundtable with FDA, Pharma, and Payor Community
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives of University of California San Francisco and industry
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date: 01/06/2020
Location: Silver Spring, MD
Subject: Verifying Accurate, Leading-edge IVCT Development (VALID) Act
FDA Participant/Group: ELLEN FLANNERY; MARCY BUSCH; AVIS DANISHEFSKY; COURTNEY LIAS; TOBY LOWE; BRITTANY SCHUCK; JENNIFER TOMASELLO; LORIE ERIKSON; KATHERINE DONIGAN; ELIZABETH HILLEBRENNER;
Non FDA Participant/Group: Allysen Mullen, Debbie Burrell, Jeff Allard, Jonathan Cohen, Priscilla Markwood (Small Biotechnology Business Coalition);
Event Date: 01/08/2020
Location: Las Vegas, NV
Subject: Consumer Technology Association Conference (Consumer Electronics Show (CES)): Digital Health Summit; Keynote Speaker: Beyond the Tweets - FDA’s Grand Vision
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Industry, academia, government, media, and other registered participants
Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event